Cargando…

Correction to: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system

Detalles Bibliográficos
Autores principales:	Ling, Kaijian, Jiang, Lupin, Liang, Shi, Kwong, Joseph, Yang, Leiyan, Li, Yudi, PingYin, Deng, Qingchun, Liang, Zhiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352327/ https://www.ncbi.nlm.nih.gov/pubmed/30700320 http://dx.doi.org/10.1186/s13048-019-0487-3

Ejemplares similares

Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system
por: Ling, Kaijian, et al.
Publicado: (2018)

Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma
por: Jiang, Lupin, et al.
Publicado: (2016)

Correction: Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
por: Li, Jinhe, et al.
Publicado: (2023)

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023)

CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
por: Kawamura, Norihiko, et al.
Publicado: (2015)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Correction: CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
por: Stemmer, Manuel, et al.
Publicado: (2017)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

Publisher Correction: Structural basis for mismatch surveillance by CRISPR–Cas9
por: Bravo, Jack P. K., et al.
Publicado: (2022)

Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2022)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)

A cytokine screen using CRISPR-Cas9 knock-in reporter pig iPS cells reveals that Activin A regulates NANOG
por: Xu, Junjun, et al.
Publicado: (2020)

Correction: Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence the outcome of mutagenic DNA repair
Publicado: (2019)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
por: Crippa, Stefania, et al.
Publicado: (2022)

Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019)

Author Correction: Rapid breeding of parthenocarpic tomato plants using CRISPR/Cas9
por: Ueta, Risa, et al.
Publicado: (2020)

Author Correction: CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep
por: Vilarino, Marcela, et al.
Publicado: (2020)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Correction to: Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction
por: Wang, Si, et al.
Publicado: (2022)

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
por: Feng, Yan, et al.
Publicado: (2016)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis”
por: Teng, Bu-Wei, et al.
Publicado: (2022)

Correction: Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
por: Das, Krishna, et al.
Publicado: (2018)

Correction to: Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen
por: Goh, Corinna Jie Hui, et al.
Publicado: (2022)

Correction to: “Retraction of: DeepCRISTL: deep transfer learning to predict CRISPR/Cas9 functional and endogenous on-target editing efficiency”
Publicado: (2023)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Author Correction: De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens
por: He, Wei, et al.
Publicado: (2020)

Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
por: Walton, Josephine B., et al.
Publicado: (2018)

Author Correction: Enhanced genome editing efficiency of CRISPR PLUS: Cas9 chimeric fusion proteins
por: Park, Jongjin, et al.
Publicado: (2021)

CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells
por: Wei, Chaogang, et al.
Publicado: (2018)

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020)

Efficient CRISPR–Cas9 mediated multiplex genome editing in yeasts
por: Wang, Laiyou, et al.
Publicado: (2018)

Applications and Prospects of CRISPR/Cas9-Mediated Base Editing in Plant Breeding
por: Li, Yizhen, et al.
Publicado: (2023)

Correction: Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers
por: Wang, Xiaolong, et al.
Publicado: (2016)

Correction to: CRISPR/Cas9-targeted mutagenesis of Os8N3 in rice to confer resistance to Xanthomonas oryzae pv. Oryzae
por: Kim, Young-Ah, et al.
Publicado: (2019)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

CRISPR/Cas9 and TALE: beyond cut and paste
por: Deng, Liping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_42a5unci3ecn6kjd8hb05cp0hv